3 Promising Penny Stocks On The ASX With Under A$2B Market Cap

In This Article:

The Australian market has recently seen a downturn, with the ASX200 closing at a seven-week low, driven by declines in sectors such as Health Care and Financials. Despite this challenging backdrop, investors may find opportunities in smaller or newer companies that are often categorized as penny stocks. Although the term might seem outdated, these stocks can still offer substantial growth potential when backed by strong financials and sound fundamentals.

Top 10 Penny Stocks In Australia

Name

Share Price

Market Cap

Financial Health Rating

Embark Early Education (ASX:EVO)

A$0.77

A$142.2M

★★★★☆☆

MaxiPARTS (ASX:MXI)

A$1.85

A$104.82M

★★★★★★

Helloworld Travel (ASX:HLO)

A$1.81

A$290.75M

★★★★★★

Austin Engineering (ASX:ANG)

A$0.52

A$325.58M

★★★★★☆

LaserBond (ASX:LBL)

A$0.62

A$71.5M

★★★★★★

Navigator Global Investments (ASX:NGI)

A$1.665

A$842.94M

★★★★★☆

Perenti (ASX:PRN)

A$1.165

A$1.09B

★★★★★★

Atlas Pearls (ASX:ATP)

A$0.135

A$61M

★★★★★★

Joyce (ASX:JYC)

A$4.33

A$128.31M

★★★★★★

EZZ Life Science Holdings (ASX:EZZ)

A$3.70

A$155.48M

★★★★★★

Click here to see the full list of 1,033 stocks from our ASX Penny Stocks screener.

Here we highlight a subset of our preferred stocks from the screener.

EZZ Life Science Holdings

Simply Wall St Financial Health Rating: ★★★★★★

Overview: EZZ Life Science Holdings Limited formulates, produces, markets, and sells health and wellbeing products across Australia, New Zealand, Mainland China, and internationally with a market cap of A$155.48 million.

Operations: The company generates revenue through its Company Owned segment, which accounts for A$62.57 million, and its Brought in Lines segment, contributing A$3.87 million.

Market Cap: A$155.48M

EZZ Life Science Holdings has experienced substantial earnings growth, with a 91.9% increase over the past year, significantly outpacing the industry average. The company is debt-free and maintains a high return on equity at 32.7%, indicating efficient use of capital. Despite shareholder dilution with shares outstanding increasing by 4%, EZZ's financial health remains robust, as short-term assets exceed liabilities comfortably. The company's net profit margin has improved to 10.5%. However, its share price has been highly volatile recently and trades below estimated fair value by a significant margin, presenting both opportunities and risks for investors in penny stocks.

ASX:EZZ Debt to Equity History and Analysis as at Nov 2024
ASX:EZZ Debt to Equity History and Analysis as at Nov 2024

Otto Energy

Simply Wall St Financial Health Rating: ★★★★★★